XOOMAR

Viking Global Investors 13F Holdings

Andreas Halvorsen · Quarter ended 2026-03-31 · Reported value $35.75B

As of the quarter ended 2026-03-31, Viking Global Investors reported 77 US-listed positions worth $35.75B. The largest is VISA INC at 5.4% of the reported portfolio, and the top five holdings make up 20% of it, a widely diversified book. Trimmed: SHERWIN WILLIAMS CO, APPLE INC, BRIDGEBIO PHARMA INC.

New positions

None detected

Added to
  • VISA INC
  • SCHWAB CHARLES CORP
  • DISNEY WALT CO
  • FORTIVE CORP
  • MCDONALDS CORP
Reduced
  • SHERWIN WILLIAMS CO
  • APPLE INC
  • BRIDGEBIO PHARMA INC
  • MICROSOFT CORP
  • ALPHABET INC

Holdings

#IssuerValue% of PortfolioSharesQoQ Shares
1VISA INC$1.91B5.4%6.33M+2.34M
2TAIWAN SEMICONDUCTOR MANUFAC$1.51B4.2%4.47M-
3SCHWAB CHARLES CORP$1.38B3.9%14.66M+792.0K
4DISNEY WALT CO$1.28B3.6%13.30M+2.10M
5FORTIVE CORP$1.24B3.5%22.48M+3.25M
6AIR PRODUCTS AND CHEMICALS I$1.19B3.3%4.10M-
7MCDONALDS CORP$1.13B3.2%3.63M+5.8K
8SHERWIN WILLIAMS CO$997.8M2.8%3.11M-59.5K
9TESLA INC$927.0M2.6%2.49M+793.8K
10APPLE INC$911.9M2.6%3.59M-1.27M
11BRIDGEBIO PHARMA INC$879.4M2.5%11.84M-2.55M
12CARVANA CO$874.0M2.4%2.78M+1.72M
13MICROSOFT CORP$854.9M2.4%2.31M-908.2K
14THERMO FISHER SCIENTIFIC INC$819.9M2.3%1.67M+874.8K
15JPMORGAN CHASE & CO$795.4M2.2%2.70M+2.58M
16CSX CORP$766.7M2.1%18.68M+4.86M
17INTERCONTINENTAL EXCHANGE IN$760.7M2.1%4.84M+33.7K
18LENNOX INTL INC$729.8M2.0%1.57M+951.1K
19ALPHABET INC$689.0M1.9%2.40M-270.4K
20FEDEX CORP$688.2M1.9%1.93M+1.28M
21GENERAL MTRS CO$683.7M1.9%9.18M+2.37M
22BOEING CO$636.1M1.8%3.20M-757.0K
23PNC FINL SVCS GROUP INC$629.9M1.8%3.03M-4.26M
24T-MOBILE US INC$623.2M1.7%2.97M-786.8K
25META PLATFORMS INC$607.9M1.7%1.06M+133.6K
26REGAL REXNORD CORPORATION$588.5M1.6%3.14M-81.1K
27MID-AMER APT CMNTYS INC$586.0M1.6%4.80M+918.4K
28JOHNSON CONTROLS INTERNATION$578.8M1.6%4.42M-
29MEDLINE INC$508.8M1.4%11.43M+4.47M
30HCA HEALTHCARE INC$508.8M1.4%1.08M+76.0K
31ATI INC$484.8M1.4%3.33M-
32CELESTICA INC$466.2M1.3%1.65M-44.2K
33CAMDEN PPTY TR$460.5M1.3%4.72M-49.1K
34CHUBB LTD SWITZ$422.1M1.2%1.30M-
35ADAPTIVE BIOTECHNOLOGIES COR$416.3M1.2%29.99M0
36BIOMARIN PHARMACEUTICAL INC$398.9M1.1%7.06M+1.03M
37SEA LTD$392.3M1.1%4.74M+1.07M
38WATERS CORP$374.2M1.0%1.26M-
39CARNIVAL CORP$355.1M1.0%13.72M-340.5K
40AON PLC$350.9M1.0%1.09M+303.5K
41HASBRO INC$350.0M1.0%3.74M-
42REDDIT INC$343.6M1.0%2.55M+2.33M
43PROGRESSIVE CORP$320.5M0.9%1.62M+285.0K
44AMERICAN INTL GROUP INC$317.6M0.9%4.22M+2.41M
45CAPITAL ONE FINL CORP$294.1M0.8%1.61M-1.34M
46DICKS SPORTING GOODS INC$250.7M0.7%1.26M-1.31M
47AMAZON COM INC$249.0M0.7%1.20M-1.93M
48AMER SPORTS INC$239.3M0.7%7.27M+2.46M
49API GROUP CORP$236.5M0.7%5.84M-5.70M
50TIC SOLUTIONS INC$235.7M0.7%35.82M+1.46M
51CBOE GLOBAL MKTS INC$193.5M0.5%688.4K-966.6K
52ROIVANT SCIENCES LTD$184.3M0.5%6.65M+209.3K
53HOME DEPOT INC$165.8M0.5%504.3K-
54GALLAGHER ARTHUR J & CO$157.5M0.4%727.4K-313.5K
55LULULEMON ATHLETICA INC$150.1M0.4%980.6K+897.5K
56NEWAMSTERDAM PHARMA COMPANY$134.6M0.4%4.20M0
57ORUKA THERAPEUTICS INC$130.8M0.4%2.67M0
58SIONNA THERAPEUTICS INC$128.1M0.4%3.20M0
59STELLANTIS N.V$111.9M0.3%15.98M-23.08M
60COREWEAVE INC$108.3M0.3%1.40M-
61VERADERMICS INC$106.8M0.3%1.69M-
62WEST PHARMACEUTICAL SVSC INC$104.5M0.3%416.9K+121.9K
63PHARVARIS N V$103.2M0.3%3.65M0
64INHIBRX BIOSCIENCES INC$96.7M0.3%1.44M0
65INTERACTIVE BROKERS GROUP IN$93.5M0.3%1.39M-
66RALLIANT CORP$88.8M0.2%2.13M-1.03M
67EDWARDS LIFESCIENCES CORP$87.9M0.2%1.10M-1.97M
68ORIC PHARMACEUTICALS INC$73.8M0.2%5.82M-748.2K
69DAMORA THERAPEUTICS INC$59.9M0.2%2.31M-
70TWILIO INC$56.7M0.2%450.8K+195.3K
71STANDARD BIOTOOLS INC$53.9M0.2%58.65M0
72TREVI THERAPEUTICS INC$38.2M0.1%3.20M0
73GINKGO BIOWORKS HOLDINGS INC$21.9M0.1%3.58M0
74EQUIPMENTSHARE COM INC$20.4M0.1%1.00M-
75FORGENT POWER SOLUTIONS INC$19.0M0.1%650.0K-
76PEPGEN INC$6.2M0.0%3.48M0
77RALLYBIO CORP$4.7M0.0%524.3K-3.67M
13F filings arrive up to 45 days after quarter end and cover US-listed long positions only. Positions may have changed since. This is observation data, not a recommendation.
🏦

Understanding

Reading Viking Global Investors's 13F

Managers running over $100M in US equities must disclose their long positions to the SEC within 45 days of each quarter end. This page parses Viking Global Investors's actual filing, the same document Bloomberg terminals and paid trackers repackage.

Read the QoQ column before the position list. A fund's largest holding is usually old news priced in years ago; what moved this quarter (new stakes, exits, big adds and trims) is where the information lives. New positions equal fresh conviction at recent prices.

Mind the blind spots: 13Fs exclude shorts, bonds, options hedges, and non-US listings, and arrive six-plus weeks stale. A fund that looks all-in long here may be market neutral in reality. Use this as a record of what they bought, never as proof of what they believe today.

Frequently Asked Questions

How current is Viking Global Investors's portfolio here?
It reflects the latest 13F-HR filing, which funds submit up to 45 days after each quarter ends. Positions may have changed since.
Why do share counts change quarter to quarter?
The QoQ column shows shares bought or sold versus the prior quarter's filing. A position equal to its change is brand new.
Does this show short positions?
No. 13F filings only disclose US-listed long positions. Shorts, bonds, and non-US holdings are not reported.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.